TrialClinical rheumatology2010

Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs.

Mariangela Atteno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.